DOI:

Reliable angiographic evaluation by 64-slice computed tomography after trifurcation stenting of the left main coronary artery

Carlos A.G. Van Mieghem*, MD; Georgios Sianos, MD, PhD; Bob Meijboom, MD; Eleni Vourvouri, MD, PhD; Patrick W. Serruys, MD, PhD; Pim J. de Feyter, MD, PhD

A 39-year-old man underwent a complex percutaneous coronary intervention of the left main trifurcation due to unstable angina. Five paclitaxel-eluting stents were implanted successfully in the 3 major branches and left main trunk (Figure 1, panels A and B).

Figure 1. Two paclitaxel eluting stents (PES) were positioned simultaneously within the intermediate branch and circumflex artery (CX) together with balloon dilatation of the left anterior descending artery (LAD) to prevent plaque shift (panel A). The stent in the CX overlapped with a more distal stent in the same branch implanted at the start of the procedure. Due to dissection of the LAD ostium another PES was positioned in the proximal LAD and a fifth stent was deployed in the left main trunk (not shown). The procedure was completed with kissing balloon inflations of the 3 branches using 2 guiding catheters (one 5 and one 6 French guiding catheter), as indicated by the arrowhead and arrow (panel B). Invasive coronary angiography showed perfect patency of the 3 branches (panel C). Intravascular ultrasound confirmed the absence of neointimal hyperplasia, as shown by the IVUS cross-sectional image of the LMCA (panel D). b indicates balloon; CX, circumflex coronary artery; IB, intermediate branch; LAD, left anterior descending coronary artery; and s, stent.

Three months later follow-up 64-slice computed tomographic (MSCT) coronary angiography demonstrated excellent stent patency without signs of neointimal hyperplasia (Figure 2).

Figure 2. 64-slice CT coronary angiogram. Volume-rendered (panel A) and multiplanar reconstructed image (panel B) showing the stented left main trifurcation. The lumen within the stents is clearly visible along the 3 branches of the trifurcation (panels C, D and E). It is obvious that the 4 stents, including the stent edges, are perfectly patent without signs of neointima hyperplasia.

Ao indicates ascending aorta; CX, circumflex coronary artery; IB, intermediate branch; LAD, left anterior descending coronary artery; RVOT, right ventricular outflow tract.

Invasive coronary angiography and intravascular ultrasound (IVUS) confirmed these findings (Figure 1, panels C and D).

Current MSCT scanners provide a promising non-invasive alternative to conventional coronary angiography in the follow-up of patients after stenting of the left main coronary artery.

Volume 1 Number 4
Feb 20, 2006
Volume 1 Number 4
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-D-26-00453 Jul 6, 2026
AnchorMan versus Watchman 2.5: a randomised comparison in left atrial appendage closure
Garot P and Nielsen-Kudsk J
free

Editorial

10.4244/EIJ-E-26-00011 Jul 6, 2026
Comparing transcatheter aortic valves: time to look beyond simplistic categorisations
Blackman D and Maznyczka A
free

Original Research

10.4244/EIJ-D-26-00158 Jul 6, 2026
Prosthesis-patient mismatch with intra-annular self-expanding valves: an analysis of the PORTICO IDE trial
Fontana G et al

Research Correspondence

10.4244/EIJ-D-26-00315 Jul 6, 2026
Validation of the VARC-HBR consensus for defining high bleeding risk in TAVI
Singh M et al

Research Correspondence

10.4244/EIJ-D-26-00271 Jul 6, 2026
Outcomes of percutaneous mechanical aspiration in left-sided infective endocarditis
Lugo-Fagundo NS et al

Flashlight

10.4244/EIJ-D-26-00128 Jul 6, 2026
Concomitant transfemoral aortic and mitral valve replacement
Lianos I et al
Trending articles
334.7

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
84.05

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
45.25

State-of-the-Art

10.4244/EIJ-D-25-01346 May 4, 2026
Slow flow and no reflow after percutaneous coronary intervention
Brugaletta S et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
38.2

State-of-the-Art

10.4244/EIJ-D-24-00195 Apr 7, 2025
Percutaneous coronary intervention for calcified and resistant lesions
Pesarini G et al
free
33.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
32.2

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
29.2

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
29.2

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved